Second-line Therapy (TASER-P)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
amfAR, Therapeutics Research, Education, and AIDS Training in Asia (TREAT Asia) through an unrestricted grant from ViiV Healthcare
Dr Cipto Mangunkusumo General Hospital
Pediatric Institute, Hospital Kuala Lumpur
Chiang Mai University
Srinagarind Hospital, Khon Kaen University, Department of Pediatrics
Mahidol University
Children's Hospital Number 1, Ho Chi Minh City, Vietnam
Children's Hospital Number 2, Ho Chi Minh City, Vietnam
The Kirby Institute for Infection and Immunity in Society
University of California, San Francisco
Information provided by (Responsible Party):
Jintanat Ananworanich, The HIV Netherlands Australia Thailand Research Collaboration
ClinicalTrials.gov Identifier:
NCT01788891
First received: February 7, 2013
Last updated: February 8, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)